The surface of drug-loaded nanocage was further tattooed with MnO2 mineralization and electrostatically modified with αPD-L1 or anti-CD47 antibody (αCD47) for the treatment of TNBC and colon adenocarcinoma (COAD), respectively. Here, CD47 is linked to colon adenocarcinoma.